Society and Social Development

One of the CSR programs of the Company focusing on the community health is Thalassemia Screening. Thalassemia is a blood disorder disease characterized by erythrocytes that are more prone to breakage or with shorter life cycle than normal ones, which can live up to 120 days.

Through thalassemia screening program, the Company helps the community to early detect the disease indications. In 2017, the Company have been conducted Thalassemia Screening to over 1000 patients in several cities namely Medan, Karawang, Bekasi, Ciamis, and Sukabumi.